CytomX Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 127
EBIT TTM (mln): 6
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 1 5 8 15 72 60 57 100 70 53 101 138
Przychód Δ r/r 0.0% 471.7% 51.9% 95.1% 376.1% -16.9% -3.4% 74.6% -30.7% -23.6% 90.4% 36.4%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 91.6% 89.0% 97.9% 100.0%
EBIT (mln) -15 -30 -33 -60 -46 -78 -111 -49 -84 -101 -6 25
EBIT Δ r/r 0.0% 99.0% 11.6% 79.5% -22.4% 68.3% 42.4% -56.2% 72.4% 21.0% -93.6% -485.5%
EBIT (%) -1684.2% -586.3% -430.5% -396.1% -64.6% -130.9% -192.9% -48.4% -120.4% -190.6% -6.4% 18.1%
Koszty finansowe (mln) 0 0 2 2 0 0 0 0 0 -2 0 0
EBITDA (mln) -14 -29 -32 -55 -45 -76 -111 -46 -84 -101 -4 25
EBITDA(%) -1601.8% -571.8% -420.5% -368.9% -62.3% -127.7% -192.9% -45.9% -120.4% -190.6% -4.3% 18.1%
Podatek (mln) 0 0 0 -0 -1 14 -0 -14 -3 -2 4 0
Zysk Netto (mln) -15 -30 -35 -59 -43 -85 -102 -33 -81 -97 -1 32
Zysk netto Δ r/r 0.0% 100.2% 16.7% 66.5% -26.8% 96.3% 20.8% -67.8% 145.2% 20.6% -99.4% -5700.9%
Zysk netto (%) -1705.3% -597.0% -458.7% -391.5% -60.2% -142.2% -177.8% -32.8% -115.9% -183.0% -0.6% 23.1%
EPS -0.43 -0.87 -4.12 -1.63 -1.16 -2.03 -2.26 -0.71 -1.26 -1.48 -0.0077 0.38
EPS (rozwodnione) -0.43 -0.87 -4.12 -1.63 -1.16 -2.03 -2.26 -0.71 -1.26 -1.48 -0.0077 0.38
Ilośc akcji (mln) 35 35 9 36 37 42 45 46 64 66 74 84
Ważona ilośc akcji (mln) 35 35 9 36 37 42 45 46 64 66 74 85
Waluta USD USD USD USD USD USD USD USD USD USD USD USD